Anxiety News and Research

Latest Anxiety News and Research

Total lockdown during COVID-19 has measurable impact on vascular health, research shows

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measurable impact on vascular health.

6 Sep 2022

Older people with insomnia more likely to develop memory decline, finds study

A new Canadian study has found that older people with insomnia are at greater risk of developing memory decline and long-term cognitive impairment such as dementia.

6 Sep 2022

Study: Premenstrual mood symptoms represent a key public health issue globally

Premenstrual mood swings and anxiety are so common – experienced by more than 64% of women – that they represent a "key public health issue globally," according to a new UVA Health study.

6 Sep 2022

Researchers present their viewpoint on the link between EBV infections and the development of MS based on a previous study

Researchers presented their viewpoint on the link between Epstein-Barr virus infections and the development of multiple sclerosis based on a previous study conducted by Bjornevik et al. published in Science.

6 Sep 2022

Neurological manifestations associated with monkeypox infection

A new study presents current information regarding the neurological presentations and complications of monkeypox infection.

5 Sep 2022

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

As cannabidiol (CBD) use rises, high quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022 Together with CardioAcademic.

5 Sep 2022

Cannabis legalization likely to reduce conventional pharmaceutical sales by billions of dollars

Researchers from California Polytechnic State University and The University of New Mexico find that stock market investors predict cannabis legalization will reduce conventional pharmaceutical sales by billions of dollars.

2 Sep 2022

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Anxiety, autism, schizophrenia and Tourette syndrome each have their own distinguishing characteristics, but one factor bridging these and most other mental disorders is circadian rhythm disruption, according to a team of neuroscience, pharmaceutical sciences and computer science researchers at the University of California, Irvine.

2 Sep 2022

Sonographers can help enhance parents' emotional connection to the unborn baby during pregnancy

A systematic review of twenty-three studies suggests that, during pregnancy, expectant parents' feelings towards their unborn baby (fetus) can be positively enhanced by sonographers (specialist healthcare professionals who are trained to perform pregnancy ultrasound scans) making imaging examinations a truly parent-centred experience.

1 Sep 2022

Early therapeutic interventions may be effective in treating Fragile X Syndrome

A new study suggests that therapeutic interventions to treat neurodevelopmental disorders may be more effective if done during the early stages of brain development.

1 Sep 2022

Brain activity patterns during sleep shed light on the neurobiology behind 22q11.2 Deletion Syndrome

The brain activity patterns during sleep shed light on the neurobiology behind a genetic condition called 22q11.2 Deletion Syndrome (22q11.2DS) and could be used as a biomarker to detect the onset of neuropsychiatric disorders in people with 22q11.2DS.

30 Aug 2022

New study aims to help people with learning disabilities to fight loneliness

People with learning disabilities are set to benefit from a new study, funded by the NIHR, by the University of Surrey that will examine ways to help them overcome loneliness - which often leads to other underlying medical issues such as heart diseases, obesity, anxiety, and depression.

30 Aug 2022

Music intervention can help bridge the gap between dementia patients and their loved ones

People with dementia often lose their ability to communicate verbally with loved ones in later stages of the disease.

29 Aug 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

Inactivation of particular protein complex associated with Parkinson's and anxiety disorders

Inactivation of a particular protein complex that plays a key role in keeping genes switched off leads to nerve cells not producing enough essential neurotransmitters.

29 Aug 2022

Many mothers of children with autism experience depressive symptoms

About 50% of all mothers of children with autism spectrum disorder (ASD) had elevated levels of depressive symptoms over 18 months, while rates were much lower (6% to 13.6%) for mothers with neurotypical children in the same period, UCSF researchers report in a new study published August 26 in Family Process.

26 Aug 2022

New guidelines recommend earlier detection and treatment of pulmonary hypertension

Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines for the diagnosis and treatment of pulmonary hypertension, published online today in European Heart Journal and the European Respiratory Journal.

26 Aug 2022

New study investigates a potential treatment for people diagnosed with monkeypox

The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox.

25 Aug 2022

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

25 Aug 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

Anxiety News and Research

Latest Anxiety News and Research

Total lockdown during COVID-19 has measurable impact on vascular health, research shows

Older people with insomnia more likely to develop memory decline, finds study

Study: Premenstrual mood symptoms represent a key public health issue globally

Researchers present their viewpoint on the link between EBV infections and the development of MS based on a previous study

Neurological manifestations associated with monkeypox infection

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

Cannabis legalization likely to reduce conventional pharmaceutical sales by billions of dollars

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Sonographers can help enhance parents' emotional connection to the unborn baby during pregnancy

Early therapeutic interventions may be effective in treating Fragile X Syndrome

Brain activity patterns during sleep shed light on the neurobiology behind 22q11.2 Deletion Syndrome

New study aims to help people with learning disabilities to fight loneliness

Music intervention can help bridge the gap between dementia patients and their loved ones

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Inactivation of particular protein complex associated with Parkinson's and anxiety disorders

Many mothers of children with autism experience depressive symptoms

New guidelines recommend earlier detection and treatment of pulmonary hypertension

New study investigates a potential treatment for people diagnosed with monkeypox

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Anxiety News and Research

Latest Anxiety News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in